![Rudolf Kwan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rudolf Kwan
Corporate Officer/Principal bei
National Institute on Drug Abuse
Profil
Rudolf Kwan is currently the Chairman of the Data Monitoring & Safety Board at the National Institute on Drug Abuse and a Member of The Royal College of Physicians.
He previously worked as the Vice President of Global Clinical Development at Chiron Corp.
and GlaxoSmithKline LLC, and as the VP & Head of Asia Pacific Global Clinical Operations at Schering-Plough Corp.
From 2008 to 2022, he served as the Chief Medical Officer at Athenex, Inc. Dr. Kwan received his undergraduate degree from the University of Hong Kong.
Aktive Positionen von Rudolf Kwan
| Unternehmen | Position | Beginn |
|---|---|---|
National Institute on Drug Abuse
 National Institute on Drug Abuse General GovernmentGovernment Provides services to prevent drug abuse | Corporate Officer/Principal | - |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Rudolf Kwan
| Unternehmen | Position | Ende |
|---|---|---|
| ATHENEXPAR | Technik-/Wissenschafts-/F&E-Leiter | 08.06.2022 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | - |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | - |
Ausbildung von Rudolf Kwan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Athenex, Inc.
 Athenex, Inc. BiotechnologyHealth Technology Develops and commercializes drugs for cancer and immunomodulatory diseases | Health Technology |
University of Hong Kong
 University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institute on Drug Abuse
National Institute on Drug Abuse General GovernmentGovernment Provides services to prevent drug abuse | Government |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Wählen Sie MarketScreener 
